Search Results 381-390 of 15983 for IUD

  1. A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of NIO752 in Participants with Progressive Supranuclear Palsy - Mayo Clinic

    rate < 1%), for example hormone vaginal ring or transdermal hormone contraception or placement of an intrauterine device (IUD) or intrauterine system (IUS).

  2. A Study to Validate Patient-Reported Outcome Instruments in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection - Mayo Clinic

    - copper intrauterine device (IUD), - hormonal methods (levonorgestrel-releasing intrauterine system, progestogen implant, combined oral contraceptive pill ...

  3. Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) - Mayo Clinic

    ... intrauterine device (IUD); intrauterine hormone-releasing system (IUS); bilateral tubal occlusion; vasectomized partner; along with barrier methods of ...

  4. 8 Week Multi-site Study of MYDAYIS® for Bipolar Depression - Mayo Clinic

    ... (IUD), tubal ligation or condoms during sexual intercourse). Otherwise excluded for administrative reasons and/or clinician judgment. Participating Mayo ...

  5. Frequently Asked Questions - Giving to Mayo Clinic

    Your tax-deductible gift will help us continue to inspire hope and contribute to health and well-being by providing the best care to every patient through ...

  6. Randomized Global Phase 3 Study to Evaluate the Impact of Obeticholic Acid Treatment on Nonalcoholic Steatohepatitis Patients - Mayo Clinic

    Intrauterine device;; Vasectomy (partner);; Hormonal (e.g., contraceptive pill, patch, intramuscular implant or injection);; Abstinence (defined as refraining ...

  7. Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer - Mayo Clinic

    Women of childbearing potential or their sexual partners who are unwilling to employ adequate contraception (condoms, diaphragm, intrauterine device [IUD], ...

  8. Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia - Mayo Clinic

    ... intrauterine device, a contraceptive implant, an oral contraceptive, or have a vasectomized partner with confirmed azoospermia) throughout the entire study ...

  9. COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease Complications - Mayo Clinic

    sponges, foams, jellies, diaphragm, intrauterine device (IUD)) throughout the study and for 30 days after study completion; - Patient or their caregiver ...

  10. A Study of Selpercatinib to Treat Participants with RET-Mutant Medullary Thyroid Cancer - Mayo Clinic

    ... intrauterine device [IUD], birth control pill, or barrier method) during treatment with study drug and for 4 months following the last dose of study drug.